ClinConnect ClinConnect Logo
Search / Trial NCT06238219

Management of Neuromuscular Blocking Agents and Their Antagonism

Launched by ERASME UNIVERSITY HOSPITAL · Feb 1, 2024

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how well hospitals are following new recommendations for the use of neuromuscular blocking agents (NMBAs) during surgeries. NMBAs are medications that help relax muscles, making it easier for doctors to perform surgeries. However, if not used correctly, they can cause problems. The trial is looking specifically at the practices in one hospital to see if the guidelines released in 2023 are being followed.

To participate in this study, patients must be scheduled for surgery that involves the use of these muscle-relaxing medications. The trial is open to all patients aged 65 and older who meet this requirement. Participants will not need to do anything extra, but their medical records will be reviewed to assess how NMBAs are being used. This study is important because it aims to improve safety and care for patients undergoing surgery with these medications.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - All patients undergoing surgery with use of neuromuscular blocking agents at our institution
  • Exclusion Criteria:
  • - Incomplete electronic anesthesia record

About Erasme University Hospital

Erasme University Hospital, a leading institution in clinical research and patient care, is dedicated to advancing medical knowledge and improving health outcomes through innovative clinical trials. As a prominent academic hospital affiliated with the Université libre de Bruxelles, it combines cutting-edge research with comprehensive clinical services, fostering collaboration among healthcare professionals, researchers, and patients. With a strong emphasis on rigorous scientific methodologies and ethical standards, Erasme University Hospital aims to contribute to the development of new therapies and treatment protocols that address pressing health challenges.

Locations

Brussels, , Belgium

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported